UBXN8 Antikörper (AA 149-270)

Produktnummer ABIN7870775

Dieser Kaninchen Polyklonal Antikörper detektiert spezifisch UBXN8 in ELISA, WB, FACS und IHC (p). Es zeigt Reaktivität gegenüber Proben von Human.

Kurzübersicht für UBXN8 Antikörper (AA 149-270) (ABIN7870775)

Target: UBXN8 (UBX Domain Protein 8 (UBXN8))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser UBXN8 Antikörper ist unkonjugiert

Applikation: ELISA, Western Blotting (WB), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Produktdetails anti-UBXN8 Antikörper

Bindungsspezifität: AA 149-270

Verwendungszweck: UBXN8 Antibody / UBX domain-containing protein 8

Aufreinigung: Antigen affinity purified

Immunogen: E. coli-derived recombinant human protein (amino acids N149-N270) was used as the immunogen for the UBXN8 antibody.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Optimal dilution of the UBXN8 antibody should be determined by the researcher.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Buffer: 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: After reconstitution, the UBXN8 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.

Details zu UBXN8

Target: UBXN8 (UBX Domain Protein 8 (UBXN8))

Andere Bezeichnung: UBXN8

Hintergrund: P97 or VCP (valosin-containing protein) is a versatile ATPase complex, and many cofactors are required for the p97 functional diversity. This gene encodes one of the p97 cofactors. This cofactor is a transmembrane protein and localized in the endoplasmic reticulum (ER) membrane. It tethers p97 to the ER membrane via its UBX domain. The association of this cofactor with p97 facilitates efficient ER-associated degradation of misfolded proteins. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.

UniProt: O00124

Pathways: SARS-CoV-2 Protein Interaktom